145 related articles for article (PubMed ID: 9479919)
21. Enhanced liver MR: contrast agents and imaging strategy.
Runge VM; Kirsch JE; Wells JW; Awh MH; Bittner DF; Woolfolk CE
Crit Rev Diagn Imaging; 1993; 34(1-2):1-30. PubMed ID: 8216813
[TBL] [Abstract][Full Text] [Related]
22. [Perfusion MR imaging of the liver with a vascular contrast agent].
Leporq B; Beuf O; Pilleul F
J Radiol; 2011 Mar; 92(3):257-61. PubMed ID: 21501767
[No Abstract] [Full Text] [Related]
23. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.
Morana G; Grazioli L; Kirchin MA; Bondioni MP; Faccioli N; Guarise A; Schneider G
Invest Radiol; 2011 Apr; 46(4):225-39. PubMed ID: 21102346
[TBL] [Abstract][Full Text] [Related]
24. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
Wang L; Van den Bos IC; Hussain SM; Pattynama PM; Vogel MW; Krestin GP
Acta Radiol; 2008 Feb; 49(1):6-18. PubMed ID: 18210307
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance contrast agents for liver imaging.
Bashir MR
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):283-93. PubMed ID: 25086930
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium-enhanced MR imaging of liver capsule and peritoneum.
Low RN
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):803-19, vii. PubMed ID: 11694439
[TBL] [Abstract][Full Text] [Related]
27. Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
Lebedis C; Luna A; Soto JA
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947
[TBL] [Abstract][Full Text] [Related]
28. Liver MR imaging: 1.5T versus 3T.
Ramalho M; Altun E; Herédia V; Zapparoli M; Semelka R
Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):321-47, vi. PubMed ID: 17893053
[TBL] [Abstract][Full Text] [Related]
29. Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance.
Runge VM; Heverhagen JT
Invest Radiol; 2018 Jul; 53(7):381-389. PubMed ID: 29462023
[TBL] [Abstract][Full Text] [Related]
30. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
31. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
32. Contrast agents for magnetic resonance imaging of the liver.
Josephson L; Groman E; Weissleder R
Targeted Diagn Ther; 1991; 4():163-87. PubMed ID: 1797156
[No Abstract] [Full Text] [Related]
33. MR imaging of the liver.
Martin DR; Danrad R; Hussain SM
Radiol Clin North Am; 2005 Sep; 43(5):861-86, viii. PubMed ID: 16098344
[TBL] [Abstract][Full Text] [Related]
34. Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Blakeborough A; Ward J; Wilson D; Griffiths M; Kajiya Y; Guthrie JA; Robinson PJ
Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701
[TBL] [Abstract][Full Text] [Related]
35. Contrast agents for MR imaging of the liver.
Semelka RC; Helmberger TK
Radiology; 2001 Jan; 218(1):27-38. PubMed ID: 11152776
[TBL] [Abstract][Full Text] [Related]
36. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Rummeny EJ; Peters PE
Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
[TBL] [Abstract][Full Text] [Related]
37. Liver masses.
Hussain SM; Semelka RC
Magn Reson Imaging Clin N Am; 2005 May; 13(2):255-75. PubMed ID: 15935311
[TBL] [Abstract][Full Text] [Related]
38. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
39. [Iron oxides as contrast agents for MRI of the liver].
Van Beers BE; Pringot J; Gallez B
J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
[TBL] [Abstract][Full Text] [Related]
40. [Super-paramagnetic iron oxide: an MRI contrast media for the reticuloendothelial system].
Gandon Y; Brunet F; Guyader D; Brissot P; Carsin M; Simon J
Ann Radiol (Paris); 1989; 32(4):267-72. PubMed ID: 2554776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
